Story thread · 3 reports / 3 sources
Solventum plans software separation to become ‘true medtech company’
medtechdive.com · 5d
The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.
First report: Solventum outlines HIS separation and raises 2026 EPS guide to $7.10-$7.20 — seekingalpha.com, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.